Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03772808 · ClinicalTrials.gov registry record · NA
Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)
A NA study, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03772808 is a NA study that has completed, run by LycoRed. The registered enrollment target is 52 participants.
The verdict
NCT03772808, a NA study, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study will evaluate LycoComfort™ supplementation in alleviating symptoms associated with LUTS, BPH, and general prostate concerns. Inflammation, oxidative stress and androgenic activity in the prostate are proven catalysts of BPH, ultimately leading to increased prostate cell proliferation. The once-daily supplement LycoComfort™, will be under investigation for symptom relief and will be taken by participants for a duration of 12 weeks.
Interventions
- DIETARY_SUPPLEMENT Lycocomfort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2019-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03772808
The ClinicalTrials.gov registry entry for NCT03772808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LycoRed, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lycocomfort is the first listed.
NCT03772808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03772808 about?
NCT03772808 is a clinical study titled "Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)". This study will evaluate LycoComfort™ supplementation in alleviating symptoms associated with LUTS, BPH, and general prostate concerns. Inflammation, oxidative stress and androgenic activity in the prostate are proven catalysts of BPH, ultimately leading to increased prostate cell proliferation. Th...
What is the current status of trial NCT03772808?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2018-11-16. Estimated completion is 2019-06-15.
What interventions are being tested in trial NCT03772808?
The interventions under investigation include: Lycocomfort (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03772808?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.